7ZRR
Crystal structure of human Urokinase-type plasminogen activator in complex with bicycle peptide inhibitor UK965
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-05-08 |
Detector | DECTRIS PILATUS 2M |
Wavelength(s) | 0.8731 |
Spacegroup name | H 3 |
Unit cell lengths | 120.906, 120.906, 42.716 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 33.120 - 1.640 |
R-factor | 0.2031 |
Rwork | 0.201 |
R-free | 0.23910 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3qn7 |
RMSD bond length | 0.008 |
RMSD bond angle | 1.550 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.580 | 1.800 |
High resolution limit [Å] | 1.640 | 1.640 |
Rmerge | 0.059 | 0.711 |
Number of reflections | 28238 | 1430 |
<I/σ(I)> | 8.5 | 1.1 |
Completeness [%] | 99.3 | |
Redundancy | 7.9 | |
CC(1/2) | 0.997 | 0.317 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4.3 | 293 | 5% PEG400, 50mM Citrato pH 4.3, 1.8 M (NH4)2SO4, 20% Ethylene glycol |